Pathfinder Wealth Consulting, Inc.
Source: SEC Form 13F · as of Mar 2026Pathfinder Wealth Consulting, Inc. holds 12 biotech & pharma companies tracked by BioSniper, totaling $7.7M in value as of Mar 2026 (SEC Form 13F).
Companies held
12
Total value held
$7.7M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 2,659 | $2.4M |
| JNJJOHNSON & JOHNSON | 4,828 | $1.2M |
| ABBVAbbVie Inc. | 3,710 | $807K |
| PMPhilip Morris International Inc | 3,468 | $573K |
| PFEPFIZER INC | 15,980 | $449K |
| ABTABBOTT LABORATORIES | 4,302 | $442K |
| AMGNAMGEN INC | 1,125 | $396K |
| ELVElevance Health Inc. | 1,216 | $356K |
| IQVIQVIA Holdings Inc. | 2,080 | $355K |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 4,647 | $256K |
| GILDGILEAD SCIENCES, INC. | 1,813 | $253K |
| NVSNovartis AG | 1,327 | $203K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.